FDA is proposing new premarket approval (PMA) requirements for all metal-on-metal hip manufacturers including the submission of clinical data demonstrating safety and effectiveness of their products.
The January 17 proposed order was released in conjunction with an FDA safety communication providing recommendations to orthopedic surgeons on measures to take, including metal ion testing and imaging examinations,...